354 related articles for article (PubMed ID: 26712769)
1. New Drugs from Marine Organisms in Alzheimer's Disease.
Russo P; Kisialiou A; Lamonaca P; Moroni R; Prinzi G; Fini M
Mar Drugs; 2015 Dec; 14(1):5. PubMed ID: 26712769
[TBL] [Abstract][Full Text] [Related]
2. Anti-Alzheimer's Molecules Derived from Marine Life: Understanding Molecular Mechanisms and Therapeutic Potential.
Kabir MT; Uddin MS; Jeandet P; Emran TB; Mitra S; Albadrani GM; Sayed AA; Abdel-Daim MM; Simal-Gandara J
Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33925063
[TBL] [Abstract][Full Text] [Related]
3. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Sonkusare SK; Kaul CL; Ramarao P
Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
[TBL] [Abstract][Full Text] [Related]
4. Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer's disease, Parkinson's disease and ischemic brain stroke: their molecular targets and action mechanisms.
Choi DY; Choi H
Arch Pharm Res; 2015 Feb; 38(2):139-70. PubMed ID: 25348867
[TBL] [Abstract][Full Text] [Related]
5. Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update.
de Freitas Silva M; Dias KST; Gontijo VS; Ortiz CJC; Viegas C
Curr Med Chem; 2018; 25(29):3491-3525. PubMed ID: 29332563
[TBL] [Abstract][Full Text] [Related]
6. Exploitation of Marine Molecules to Manage Alzheimer's Disease.
Silva M; Seijas P; Otero P
Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34203244
[TBL] [Abstract][Full Text] [Related]
7. Marine derived bioactive compounds for treatment of Alzheimer's disease.
Lakshmi S; Prakash P; Essa MM; Qoronfleh WM; Akbar M; Song BJ; Kumar S; Elumalai P
Front Biosci (Elite Ed); 2018 Jun; 10(3):537-548. PubMed ID: 29772526
[TBL] [Abstract][Full Text] [Related]
8. Marine natural products: bryostatins in preclinical and clinical studies.
Kollár P; Rajchard J; Balounová Z; Pazourek J
Pharm Biol; 2014 Feb; 52(2):237-42. PubMed ID: 24033119
[TBL] [Abstract][Full Text] [Related]
9. Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders.
Catanesi M; Caioni G; Castelli V; Benedetti E; d'Angelo M; Cimini A
Mar Drugs; 2021 Jan; 19(1):. PubMed ID: 33430021
[TBL] [Abstract][Full Text] [Related]
10. Stratification of patients is the way to go to develop neuroprotective/disease-modifying drugs for Alzheimer's disease.
Iqbal K; Chohan MO; Grundke-Iqbal I
J Alzheimers Dis; 2008 Oct; 15(2):339-45. PubMed ID: 18953118
[TBL] [Abstract][Full Text] [Related]
11. Therapeutics of Alzheimer's disease: Past, present and future.
Anand R; Gill KD; Mahdi AA
Neuropharmacology; 2014 Jan; 76 Pt A():27-50. PubMed ID: 23891641
[TBL] [Abstract][Full Text] [Related]
12. Marine Organisms as Alkaloid Biosynthesizers of Potential Anti-Alzheimer Agents.
Lima E; Medeiros J
Mar Drugs; 2022 Jan; 20(1):. PubMed ID: 35049930
[TBL] [Abstract][Full Text] [Related]
13. Prospects of Marine Sterols against Pathobiology of Alzheimer's Disease: Pharmacological Insights and Technological Advances.
Rahman MA; Dash R; Sohag AAM; Alam M; Rhim H; Ha H; Moon IS; Uddin MJ; Hannan MA
Mar Drugs; 2021 Mar; 19(3):. PubMed ID: 33804766
[TBL] [Abstract][Full Text] [Related]
14. How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease?
Gauthier S; Leuzy A; Rosa-Neto P
Neurodegener Dis; 2014; 13(2-3):197-9. PubMed ID: 23942173
[TBL] [Abstract][Full Text] [Related]
15. Prevention studies in Alzheimer's disease: progress towards the development of new therapeutics.
Coley N; Gallini A; Andrieu S
CNS Drugs; 2015 Jul; 29(7):519-28. PubMed ID: 26188654
[TBL] [Abstract][Full Text] [Related]
16. Advances in Alzheimer's disease drug development.
Rafii MS; Aisen PS
BMC Med; 2015 Mar; 13():62. PubMed ID: 25857341
[TBL] [Abstract][Full Text] [Related]
17. Methodologies Related to Computational Models in View of Developing Anti-Alzheimer Drugs: An Overview.
Baheti K; Kale M
Curr Drug Discov Technol; 2019; 16(1):66-73. PubMed ID: 29663890
[TBL] [Abstract][Full Text] [Related]
18. The Potential Effect of Fluorinated Compounds in the Treatment of Alzheimer's Disease.
Gomes B; Loureiro JA; Coelho MA; Pereira Mdo C
Curr Pharm Des; 2015; 21(39):5725-35. PubMed ID: 25633120
[TBL] [Abstract][Full Text] [Related]
19. Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule?
Serafini MM; Catanzaro M; Rosini M; Racchi M; Lanni C
Pharmacol Res; 2017 Oct; 124():146-155. PubMed ID: 28811228
[TBL] [Abstract][Full Text] [Related]
20. Plant alkaloids as drug leads for Alzheimer's disease.
Ng YP; Or TC; Ip NY
Neurochem Int; 2015 Oct; 89():260-70. PubMed ID: 26220901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
